Jenkins excelled at defensive end at Salmen before transferring for PJP II before his senior season. His first game as a ...
Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback